Brief ReportBrief Report

The Effect of Veteran Status and Chronic Pain on Past 30-Day Sedative Use Among Community-Dwelling Adult Males

Ayodeji Otufowora, Yiyang Liu, Aderonke Okusanya, Afeez Ogidan, Adedoyin Okusanya and Linda B. Cottler
The Journal of the American Board of Family Medicine March 2024, jabfm.2023.230226R2; DOI: https://doi.org/10.3122/jabfm.2023.230226R2

References

  1. 1.↵
    1. Agarwal SD,
    2. Landon BE
    . Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open 2019;2:e187399.
    OpenUrl
  2. 2.
    1. Lembke A,
    2. Papac J,
    3. Humphreys K
    . Our other prescription drug problem. N Engl J Med 2018;378:693–5.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Olfson M,
    2. King M,
    3. Schoenbaum M
    . Benzodiazepine use in the United States. JAMA Psychiatry 2015;72:136–42.
    OpenUrl
  4. 4.↵
    1. Sonnenberg CM,
    2. Bierman EJM,
    3. Deeg DJH,
    4. Comijs HC,
    5. van Tilburg W,
    6. Beekman ATF
    . Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatry Psychiatr Epidemiol 2012;47:293–301.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Bachhuber MA,
    2. Hennessy S,
    3. Cunningham CO,
    4. Starrels JL
    . Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health 2016;106:686–8.
    OpenUrlCrossRefPubMed
  6. 6.
    1. Caplan JP,
    2. Epstein LA,
    3. Quinn DK,
    4. Stevens JR,
    5. Stern TA
    . Neuropsychiatric effects of prescription drug abuse. Neuropsychol Rev 2007;17:363–80.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Goodwin RD,
    2. Hasin DS
    . Sedative use and misuse in the United States. Addiction 2002;97:555–62.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Montenegro M,
    2. Veiga H,
    3. Deslandes A,
    4. et al
    . Neuromodulatory effects of caffeine and bromazepam on visual event-related potential (P300): a comparative study. Arq Neuropsiquiatr 2005;63:410–5.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Tarter RE,
    2. Ammerman RT,
    3. Ott PJ
    1. Sloan JW,
    2. Wala EP
    . Pharmacology of sedatives, hypnotics, and anxiolytics. In: Handbook of substance abuse. Tarter RE, Ammerman RT, Ott PJ, eds. Boston, MA: Springer US; 1998:395–433.
  10. 10.↵
    1. Bertram G,
    2. Anthony J. T
    . Sedative-hypnotic drugs. In: Basic & clinical pharmacology. 13e Eds. New York: McGraw-Hill; 2015.10.
  11. 11.↵
    1. Vozoris NT,
    2. Leung RS
    . Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data. Sleep 2011;34:869–74.
    OpenUrlPubMed
  12. 12.↵
    US Department of Veterans Affairs. Veteran population. National Center for Veterans Analysis and Statistics. Available at: https://www.va.gov/vetdata/veteran_population.asp. Published August 3, 2023. Accessed February 25, 2020.
  13. 13.↵
    1. Gressler LE,
    2. Martin BC,
    3. Hudson TJ,
    4. Painter JT
    . Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain 2018;159:451–9.
    OpenUrlPubMed
  14. 14.↵
    The Opioid Therapy for Chronic Pain Work Group. VA/DoD Clinical practice guideline for opioid therapy for chronic pain. Department of Veterans Affairs Department of Defense; 2017.
  15. 15.↵
    1. Sun EC,
    2. Dixit A,
    3. Humphreys K,
    4. Darnall BD,
    5. Baker LC,
    6. Mackey S
    . Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ 2017;356:j760.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Park TW,
    2. Saitz R,
    3. Ganoczy D,
    4. Ilgen MA,
    5. Bohnert ASB
    . Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015;350:h2698.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Kim HS,
    2. McCarthy DM,
    3. Mark Courtney D,
    4. Lank PM,
    5. Lambert BL
    . Benzodiazepine-opioid co-prescribing in a national probability sample of ED encounters. Am J Emerg Med 2017;35:458–64.
    OpenUrl
  18. 18.
    1. Jeffery MM,
    2. Hooten WM,
    3. Jena AB,
    4. Ross JS,
    5. Shah ND,
    6. Karaca-Mandic P
    . Rates of physician co-prescribing of opioids and benzodiazepines after the release of the centers for disease control and prevention guidelines in 2016. JAMA Netw Open 2019;2:e198325.
    OpenUrl
  19. 19.↵
    1. Karaca-Mandic P,
    2. Meara E,
    3. Morden NE
    . The growing problem of co-treatment with opioids and benzodiazepines. BMJ 2017;356:j1224.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Larochelle MR,
    2. Zhang F,
    3. Ross-Degnan D,
    4. Wharam JF
    . Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010. Pharmacoepidemiol Drug Saf 2015;24:885–92.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Blanco C,
    2. Han B,
    3. Jones CM,
    4. Johnson K,
    5. Compton WM
    . Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the united states. J Clin Psychiatry 2018;79:
  22. 22.↵
    1. Li C,
    2. Santaella-Tenorio J,
    3. Mauro PM,
    4. Martins SS
    . Past-year use of prescription opioids and/or benzodiazepines among adults in the United States: estimating medical and nonmedical use in 2015-2016. Drug Alcohol Depend 2019;204:107458.
    OpenUrl
  23. 23.↵
    1. Yarborough BJH,
    2. Stumbo SP,
    3. Stoneburner A,
    4. et al
    . Correlates of benzodiazepine use and adverse outcomes among patients with chronic pain prescribed long-term opioid therapy. Pain Med 2019;20:1148–55.
    OpenUrl
  24. 24.
    1. Calhoun PS,
    2. Elter JR,
    3. Jones ER,
    4. Kudler H,
    5. Straits-Tröster K
    . Hazardous alcohol use and receipt of risk-reduction counseling among U.S. veterans of the wars in Iraq and Afghanistan. J Clin Psychiatry 2008;69:1686–93.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.
    1. Bradley K,
    2. Williams E,
    3. Achtmeyer C,
    4. Volpp B,
    5. Collins B,
    6. Kivlahan D
    . Implementation of evidence-based screening in the Veterans Health Administration. Am J Manag Care 2006;12:597–606.
    OpenUrlPubMedWeb of Science
  26. 26.↵
    1. Hoge CW,
    2. Auchterlonie JL,
    3. Milliken CS
    . Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA 2006;295:1023–32.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.
    1. Bray RM,
    2. Pemberton MR,
    3. Lane ME,
    4. Hourani LL,
    5. Mattiko MJ,
    6. Babeu LA
    . Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med 2010;175:390–9.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.
    1. Bray RM,
    2. Hourani LL
    . Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005. Addiction 2007;102:1092–101.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Seal KH,
    2. Bertenthal D,
    3. Maguen S,
    4. Gima K,
    5. Chu A,
    6. Marmar CR
    . Getting beyond “Don’t ask; don't tell”: an evaluation of US Veterans Administration post-deployment mental health screening of veterans returning from Iraq and Afghanistan. Am J Public Health 2008;98:714–20.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Randall M,
    2. Kilpatrick KE,
    3. Pendergast JF,
    4. Jones KR
    . Differences in patient characteristics between Veterans Administration and community hospitals: implications for VA planning. JSTOR 1987;25: Available at: https://www.jstor.org/stable/3765398. Accessed August 21, 2019.
  31. 31.↵
    1. Spelman JF,
    2. Hunt SC,
    3. Seal KH,
    4. Burgo-Black AL
    . Post-deployment care for returning combat veterans. J Gen Intern Med 2012;27:1200–9.
    OpenUrlCrossRefPubMed
  32. 32.↵
    U.S. Department of Veterans Affairs. VA Health Care Utilization by Recent Veterans. Public Health. Available at: https://www.publichealth.va.gov/epidemiology/reports/oefoifond/health-care-utilization/. Published August 5 2020. Accessed August 26, 2023.
  33. 33.↵
    1. Rogers WH,
    2. Kazis LE,
    3. Miller DR,
    4. et al
    . Comparing the health status of VA and non-VA ambulatory patients: the veterans’ health and medical outcomes studies. J Ambul Care Manage 2004;27:249–62.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Washington DL,
    2. Farmer MM,
    3. Mor SS,
    4. Canning M,
    5. Yano EM
    . Assessment of the healthcare needs and barriers to VA use experienced by women veterans findings from the National Survey of Women Veterans. Med Care 2014;53:S23–S31.
    OpenUrl
  35. 35.↵
    1. Hynes DM,
    2. Koelling K,
    3. Stroupe K,
    4. et al
    . Veterans’ access to and use of Medicare and Veterans Affairs health care. Med Care 2007;45:214–23.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Nahin RL
    . Severe pain in veterans: the effect of age and sex, and comparisons with the general population. J Pain 2017;18:247–54.
    OpenUrlPubMed
  37. 37.
    1. Teachman J
    . Are veterans healthier? Military service and health at age 40 in the all-volunteer era. Soc Sci Res 2011;40:326–35.
    OpenUrlCrossRef
  38. 38.↵
    1. Barrett DH,
    2. Boehmer TK,
    3. Boothe VL,
    4. Flanders WD,
    5. Barrett DH
    . Health-related quality of life of U.S. military personnel: a population-based study. Mil Med 2003;168:941–7.
    OpenUrlPubMedWeb of Science
  39. 39.↵
    1. Alving B,
    2. Dai K,
    3. Chan SHH
    1. Cottler LB,
    2. Striley CW,
    3. O’Leary CC,
    4. Ruktanonchai CW,
    5. Wilhelm KA
    . Engaging the community in research with the HealthStreet model: national and international perspectives. In: Translational Medicine - What, Why and How: An International Perspective. Alving B, Dai K, Chan SHH, eds. Vol 3. Translational research in biomedicine. Basel: S. Karger AG; 2012:98–109.
    OpenUrl
  40. 40.↵
    1. Kelley ML,
    2. Bravo AJ,
    3. Votaw VR,
    4. Stein E,
    5. Redman JC,
    6. Witkiewitz K
    . Opioid and sedative misuse among veterans wounded in combat. Addict Behav 2019;92:168–72.
    OpenUrl
  41. 41.
    1. Hawkins EJ,
    2. Malte CA,
    3. Imel ZE,
    4. Saxon AJ,
    5. Kivlahan DR
    . Prevalence and trends of benzodiazepine use among Veterans Affairs patients with post-traumatic stress disorder, 2003–2010. Drug Alcohol Depend 2012;124:154–61.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Golub A,
    2. Bennett AS
    . Substance use over the military-veteran life course: an analysis of a sample of OEF/OIF veterans returning to low-income predominately minority communities. Addict Behav 2014;39:449–54.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Hoge CW,
    2. Castro CA,
    3. Messer SC,
    4. McGurk D,
    5. Cotting DI,
    6. Koffman RL
    . Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004;351:13–22.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.
    1. Stimpson NJ,
    2. Thomas HV,
    3. Weightman AL,
    4. Dunstan F,
    5. Lewis G
    . Psychiatric disorder in veterans of the Persian Gulf War of 1991. Br J Psychiatry 2003;182:391–403.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Dobkin C,
    2. Shabani R
    . The health effects of military service: evidence from the Vietnam draft. Econ Inq 2009;47:69–80.
    OpenUrlCrossRefWeb of Science
  46. 46.↵
    1. Gironda RJ,
    2. Clark ME,
    3. Massengale JP,
    4. Walker RL
    . Pain among veterans of operations enduring freedom and Iraqi freedom. academic.oup.com 2006;7:339–43. Available at: https://academic.oup.com/painmedicine/article-abstract/7/4/339/1937835. Accessed August 22, 2019.
    OpenUrl
  47. 47.↵
    1. Hwang CS,
    2. Kang EM,
    3. Kornegay CJ,
    4. Staffa JA,
    5. Jones CM,
    6. McAninch JK
    . Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014. Am J Prev Med 2016;51:151–60.
    OpenUrlPubMed
  48. 48.↵
    1. Cunningham JL,
    2. Craner JR,
    3. Evans MM,
    4. Hooten WM
    . Benzodiazepine use in patients with chronic pain in an interdisciplinary pain rehabilitation program. J Pain Res 2017;10:311–7.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Otufowora A
    . Re: “Predicting risk for opioid misuse in chronic pain with a single-item measure of catastrophic thinking”. J Am Board Fam Med 2018;31:490.
    OpenUrlFREE Full Text
  50. 50.↵
    1. Maust DT,
    2. Kales HC,
    3. Wiechers IR,
    4. Blow FC,
    5. Olfson M
    . No end in sight: benzodiazepine use in older adults in the United States. J Am Geriatr Soc 2016;64:2546–53.
    OpenUrl
  51. 51.
    1. Cook B,
    2. Creedon T,
    3. Wang Y,
    4. et al
    . Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse. Drug Alcohol Depend 2018;187:29–34.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Maust DT,
    2. Lin LA,
    3. Blow FC
    . Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv 2019;70:97–106.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Meghani SH,
    2. Keane A
    . Preference for analgesic treatment for cancer pain among African Americans. J Pain Symptom Manage 2007;34:136–47.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.
    1. Meghani SH,
    2. Byun E,
    3. Gallagher RM
    . Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med 2012;13:150–74.
    OpenUrlPubMed
  55. 55.
    1. Todd KH,
    2. Samaroo N,
    3. Hoffman JR
    . Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993;269:1537–9.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Motov SM,
    2. Khan AN
    . Problems and barriers of pain management in the emergency department: Are we ever going to get better? JPR 2008;2:5–11.
    OpenUrl
  57. 57.↵
    1. Pletcher MJ,
    2. Kertesz SG,
    3. Kohn MA,
    4. Gonzales R
    . Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 2008;299:70–8.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    Drugs.com. Zolpidem - FDA prescribing information, side effects and uses. drugs.com. Available at: https://www.drugs.com/pro/zolpidem.html. Published February 2019;27. Accessed February 28, 2020.
  59. 59.
    Xanax: uses, dosage, side effects & warnings. drugs.com. Available at: https://www.drugs.com/xanax.html. Published March 2019;4:Drugscom. Accessed March 5, 2020.
  60. 60.
    Drugs.com. Valium (diazepam): uses, dosage, side effects. Drugs.com. Available at: https://www.drugs.com/valium.html. Published February 2019;3. Accessed March 2, 2020.
  61. 61.↵
    1. Whiteside LK,
    2. Bohnert AS,
    3. Walton MA,
    4. Blow FC,
    5. Zimmerman M,
    6. Cunningham RM
    . Prevalence and correlates of nonmedical prescription opiate and nonmedical prescription sedative use among a group of adolescents and young adults with current drug use in an urban emergency department. Drug Alcohol Depend 2014;140:e242–e243.
    OpenUrl
  62. 62.↵
    1. Thomas JL,
    2. Wilk JE,
    3. Riviere LA,
    4. McGurk D,
    5. Castro CA,
    6. Hoge CW
    . Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. JAMA Psychiatry 2010;67:614–23.
    OpenUrl
  63. 63.↵
    1. Yoon G,
    2. Petrakis IL,
    3. Rosenheck RA
    . Correlates of major depressive disorder with and without comorbid alcohol use disorder nationally in the Veterans Health Administration. Am J Addict 2015;24:419–26.
    OpenUrl
  64. 64.↵
    1. Seelig AD,
    2. Jacobson IG,
    3. Smith B
    , Millennium Cohort Study Teamet al. Sleep patterns before, during, and after deployment to Iraq and Afghanistan. Sleep. 2010;33:1615–22.
    OpenUrlPubMedWeb of Science
  65. 65.↵
    1. McCaskill-Stevens W,
    2. Pinto H,
    3. Marcus AC,
    4. et al
    . Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association. J Clin Oncol 1999;17:1029–39.
    OpenUrlAbstract/FREE Full Text
  66. 66.
    1. Crawley LM
    . African-American participation in clinical trials: situating trust and trustworthiness. J Natl Med Assoc 2001;93:14S–7S.
    OpenUrlPubMed
  67. 67.↵
    1. Heller C,
    2. Balls-Berry JE,
    3. Nery JD,
    4. et al
    . Strategies addressing barriers to clinical trial enrollment of under-represented populations: a systematic review. Contemp Clin Trials 2014;39:169–82.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords